{"entity":{"type":"insider","cik":"0001760391","url":"/insider/0001760391","json_url":"/insider/0001760391.json","name":"FEES JESSICA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2021-02-03","last":"2023-08-11","span_basis":"filed_date"},"name_variants":[{"name":"FEES JESSICA","source":"filing","n_filings":5,"first_seen":"2021-02-03","last_seen":"2023-08-11"}],"transactions":[{"id":8726641,"accession":"0001209191-23-045495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045495","line_url":"/filing/0001209191-23-045495#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001760391","owner_name":"FEES JESSICA","owner_display_name":"FEES JESSICA","owner_url":"/insider/0001760391","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9434.0,"shares_display":"9,434","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":8867.96,"total_display":"8,867.96","total_whole":"8,868","shares_owned_after":101915.0,"shares_owned_after_display":"101,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-11","scope":"insider"},{"id":6330350,"accession":"0001209191-22-044672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044672","line_url":"/filing/0001209191-22-044672#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001760391","owner_name":"FEES JESSICA","owner_display_name":"FEES JESSICA","owner_url":"/insider/0001760391","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5980.0,"shares_display":"5,980","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":10285.6,"total_display":"10,285.60","total_whole":"10,286","shares_owned_after":111349.0,"shares_owned_after_display":"111,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-05","scope":"insider"},{"id":6480597,"accession":"0001209191-22-003399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-003399","line_url":"/filing/0001209191-22-003399#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001760391","owner_name":"FEES JESSICA","owner_display_name":"FEES JESSICA","owner_url":"/insider/0001760391","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19854.0,"shares_display":"19,854","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":121109.4,"total_display":"121,109.40","total_whole":"121,109","shares_owned_after":79329.0,"shares_owned_after_display":"79,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2022-01-14","scope":"insider"},{"id":4137689,"accession":"0001209191-21-009058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009058","line_url":"/filing/0001209191-21-009058#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001760391","owner_name":"FEES JESSICA","owner_display_name":"FEES JESSICA","owner_url":"/insider/0001760391","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.45,"price_display":"12.45","price_state":"stated","total_value":18675.0,"total_display":"18,675.00","total_whole":"18,675","shares_owned_after":99183.0,"shares_owned_after_display":"99,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":5373644,"accession":"0001209191-21-007549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-007549","line_url":"/filing/0001209191-21-007549#line-1","is_derivative":false,"issuer_cik":"0001718108","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001718108","owner_cik":"0001760391","owner_name":"FEES JESSICA","owner_display_name":"FEES JESSICA","owner_url":"/insider/0001760391","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":16785.0,"total_display":"16,785.00","total_whole":"16,785","shares_owned_after":100683.0,"shares_owned_after_display":"100,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2021-02-03","last_seen":"2023-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760391","retrieved_at":"2026-08-22T18:41:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}